Back to search

National and Kapodistrian University of Athens

Μοριακή γενετική διερεύνηση ασθενών με πρώιμη επιληπτική και πρώιμη μιτοχονδριακή εγκεφαλοπάθεια

Abstract

dc:description

Introduction: Developmental and epileptic encephalopathies (DEEs) are a specific category of epileptic syndromes and are caused due to defects in neuron-expressed genes encoding for either channels, or proteins that have crucial role in the correct function of synapses, or transcription factors (as well as other proteins) with regulatory action in various cellular processes. To date over 100 different DEEs have been described and almost daily new genes are discovered and associated with this clinical entity. Genetic diagnosis of DEEs involves the detection of pathogenic or likely pathogenic variants in a potentially large number of genes, and this constitutes a large challenge. The broad phenotypic heterogeneity, the overlap of clinical features between different epileptic syndromes and the large number of genes involved in epileptogenesis make differential diagnosis difficult, and thus the identification of the specific genetic defect(s) and the underlying mechanism(s) are necessary for a final diagnosis in most patients. Aim: The present work aims to study the underlying genetic mechanisms that lead to epileptogenesis in patients with DEE through the targeted screening for variants in previously associated genes (MECP2, CDKL5, FOXG1, ARX, SCN1A or POLG) and, in epilepsy patients with or without accompanying global developmental delay via Next generation sequencing (ΝGS). The overall study will also include the pattern of X-inactivation in females with variants in X-linked genes, the recording of phenotypic heterogeneity, the submission of novel variants in databases according to their classification, the search for new genotype-phenotype associations and the comparison of the diagnostic yield using different molecular techniques. Materials and Methods: 48 patients were studied for variants in CDKL5 and FOXG1 genes, 42 in ARX, 6 in POLG, 122 in MECP2 and 270 in SCN1A. With NGS 107 patients were studied. Results: NGS detected pathogenic or likely pathogenic variants in 64 patients leading to a diagnostic yield of 59,8%, in comparison to targeted gene studies that resulted in a diagnostic yield of 9,88%. Amongst the variants observed, there are molecular defects in new genes or in genes not yet clearly involved in epileptogenesis, whereby such results potentially contribute to the elucidation of new, or clearer characterization of existing clinical entities. Conclusions: The current diagnostic approach is clearly more efficient with the use of NGS than the targeted screening of a single gene or the use of epilepsy gene panels as recorded by international guidelines when testing for epilepsy syndromes. The ability to reanalyze NGS data contributes to the final diagnosis of the patients due to the continuous discovery of new genotype-phenotype associations; while the discovery of unexpected genetic defects reflects the ever-evolving knowledge of the genetic background underlying epileptogenesis.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Veltra, Danai
  • Βέλτρα, Δανάη

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/52822

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Veltra, Danai; Βέλτρα, Δανάη. Μοριακή γενετική διερεύνηση ασθενών με πρώιμη επιληπτική και πρώιμη μιτοχονδριακή εγκεφαλοπάθεια. National and Kapodistrian University of Athens, 2022. http://hdl.handle.net/10442/hedi/52822